preventive vaccine is presently fully effective against HCV. d'Arsonval, 69437 Lyon, France In 1996, in France, the prevalence of anti-HCV antibodies 6 To whom correspondence should be addressed was~1%. About 550 000 persons are chronically infected with HCV: among them, 400 000 to 500 000 are viraemic for Medical assistance for procreation in a couple where one HCV (Roudot-Thoraval et al., 1993) . In sera, the main genoor both parents has hepatitis C viral infection (HCV) raises types are 1b (50%, decreasing, observed mostly after contamthe issue of the transmission of the infection to the baby ination through transfusions), 1a and 3a (increasing, observed and/or of possible contamination of both the technicians in drug-addicted patients). and the gametes or embryos from virus-free parents in the Transmission of HCV occurs mainly through the parenteral laboratory. It becomes essential to assess transmission risk route, up to 80% of persons exhibiting anti-HCV antibodies in assisted reproductive techniques in order to define clearly having a history of a parenteral exposure, and through the use the management of couples according to their viral status.
of i.v. drugs or non-screened blood products. A French study To define the HCV transmissibility risk in assisted repro- (Roudot-Thoraval et al., 1996) analysed 6664 patients with duction related to the presence of virus in semen from chronic hepatitis C and concluded that 37% received contamininfected infertile men, HCV RNA detection was performed ated blood products (before March 1990) or were haemophilic in sera, and semen and sperm fractions obtained after patients, 23.1% were i.v. drug abusers, 3.3% could be clearly Percoll gradient centrifugation. HCV RNA was detected attributed to professional transmission (medical context, in 5% (2/39) of the semen samples tested: in the raw semen, nurses), 1.2% to sexual contact, and 14.9% to nosocomial in the seminal fluid and in the cell pellet but never after transmission (haemodialysis), while the source of HCV was Percoll selection. According to these results, we suggest a unknown in the remaining 23.8%. strategy for HCV-infected infertile men who need assistance Professional transmission also exists: 46% of professional for procreation.
hepatitis in 'Assistance Publique' hospitals in Paris in 1991 Key words: assisted reproductive techniques/hepatitis C virus/ were attributed to HCV, and hepatitis C seroconversion has viral screening been demonstrated in hospital employees with needlestick injuries (Kiyosawa et al., 1991) . The estimated risk of vertical HCV transmission varies Introduction widely in the literature according to the study population and the tests used. In a prospective study, the authors concluded The risk of viral transmissibility in assisted reproduction is still much debated, especially for hepatitis C virus (HCV) and that there was a complete lack of vertical transmission of HCV in HIV seronegative women, even in the presence of active in recent assisted fertilization techniques. Viral screening policies in assisted reproduction techniques differ in each HCV replication (Roudot-Thoraval et al., 1993) . In another study, none of the babies of the HCV RNA-negative women country, and sometimes even between infertility centres (Abusheikha et al., 1999) . Within the context of careful routine were positive for HCV RNA, but maternal transmission of HCV could be observed in babies born to mothers with high screening prior to each assisted reproduction attempt, the French bioethical law (Loi, 1994) makes provision for health levels of viraemia (Ͼ10 6 copies/ml) (Ohto et al., 1994) . The exact risk of mother-to-child transmission of HCV has not yet security rules by announcing official guidelines that have only recently been published (Arrêté, 1999) : assisted reproduction been quantified and the factors influencing the risk of this transmission remain to be evaluated (Gillet et al., 1996) . for HCV-infected male or female infertile patients is not authorized, except after agreement by two committees in a Although the parenteral mode of HCV transmission is well established, there remains a high proportion of patients without long and thorough procedure. Since the publication of these guidelines (Arrêté, 1999) Numata et al., 1993; Young et al., 1993) but remains was taking any antiviral medication: however, three patients needed controversial in semen (Hsu et al., 1991; Fried et al., 1992) . To specific antiretroviral bitherapy (interferon alpha and ribavirin) but study sexual transmission, epidemiological data were collected preferred to undergo the IVF procedure first because of the adverse (Bresters et al., 1993) and semen of HCV-infected patients effects of ribavirin.
was analysed for the presence of HCV RNA (Fried et al., HCV detection in semen 1992; Fiore et al., 1995) . Such studies yielded contradictory
Ejaculates were collected into sterile containers by masturbation after results (Table IV) . McKee (1996) to false-negative polymerase chain reaction (PCR) results due and the seminal fluid (fraction 3) was separated from the cell pellet to the presence of Taq polymerase inhibitors in seminal fluid (fraction 2). Another millilitre was submitted to centrifugation through (Levy et al., 1997) . Such inhibitors in seminal fluid were a three-layer (3 ml of 50%, 70% and 90% respectively) discontinuous detected by Semprini et al. (Semprini et al., 1998) , 1991; Massey et al., 1996) .
containing selected spermatozoa exhibiting a high proportion of
In this study, we looked for HCV RNA in the semen of motile and normal-shaped spermatozoa; all the samples were kept HCV viraemic male patients. To understand which seminal
frozen at -80°C until tested later for HCV. The different steps of the fraction could serve as a reservoir for the virus and to test the procedure were carried out within 2 h of ejaculation. This is important sperm fraction used in IVF, we tested the ejaculates, the cellto note because of the possible action of RNAses.
free seminal plasma, cell pellet and spermatozoa.
RNA extraction RNA extraction was performed on seven semen fractions for each
Materials and methods
patient: ejaculate (sample 1), cell-free seminal plasma (sample 3), cell pellet (sample 2), and, after Percoll selection, seminal plasma Study population (sample 4), 50% (sample 5), 70% (sample 6) and 90% motile In all, 39 infertile patients (31-47 years old) who entered our IVF spermatozoa (sample 7). RNA extraction was performed according programme gave their fully informed written consent for using spare to the Amplicor HCV Specimen Preparation Kit (Roche SA) which semen for research or diagnostic purposes. All were HIV-negative, was not specific for semen. hepatitis B antigen-negative but had anti-HCV antibodies and detect-HCV RNA tests able serum HCV RNA. Blood plasma HCV RNA was quantified Semen samples were tested using a reverse transcription assay with using the HCV-Monitor technique (Roche SA, Neuilly-sur-Seine, a commercial kit for amplification and detection of HCV RNA France) or the bDNA technique (Chiron Ciba Corning, Parc des (Amplicor HCV Amplification Kit and Detection Kit; Roche SA). Bellevues, France), according to the manufacturer's instructions. All dUTP-uracil-DNA-glycosylase (Boehringer Mannheim, Mannheim, subjects were asymptomatic with active chronic hepatitis.
Germany) was included for carry-over prevention of false-positive HCV infection could be clearly attributed to blood products or results. All samples were tested in triplicate together with negative haemophilia for five (13%) and three (7%) patients respectively; 12 control samples, including HCV-negative serum and reagent blanks, (31%) were intravenous drug abusers. No HCV infection could be to exclude contamination. The sensitivity of this assay is 100 copies attributed to professional contamination or sexual contact. For three of HCV genomes/ml. patients (7%), HCV infection could be related to nosocomial transmission (one through transplantation, one through endoscopy, one through
Test for PCR inhibitors
In enzyme-based amplification processes, such as PCR, efficiency haemodialysis). For 16 patients (38%), contamination circumstances remained unknown. All had increased alanine amino-transferase.
can be reduced by inhibitors that may be present in the clinical specimen. Inhibitors of PCR reaction in semen fractions have been Semen parameters were evaluated following the criteria of the World Health Organization (WHO, 1992) and are given (Table I) .
reported, but their exact nature is still unknown. To validate the negative results for HCV RNA, we used the AMPLICOR Internal Semen analysis was normal for 27 patients whereas 12 showed abnormalities: two oligozoospermia and 10 oligoasthenoteratozooControl (IC) Detection Kit (Roche SA) in conjunction with the Amplicor Microwell Plate (MWP; Roche SA) which identifies prospermia. The IVF indication was supported by male factor infertility in 30%, a female factor in 40% and by both male and female factors cessed specimens containing substances that may interfere with PCR amplification (Table II) . In these tests, an IC is introduced into each in 10% of the samples. Six couples had previously conceived children: and similar results were observed: inhibitors were detected in that must be performed on both partners of infertile couples before their enrolment for assisted reproduction techniques.
Results
Positive anti-HCV antibody detection in patients' serum raises the medico-legal aspect which has resulted in most French Of the 39 male infertile patients with HCV RNA-positive sera, two had HCV RNA detectable in semen (Tables II and III). IVF teams no longer carrying out the IVF procedure since the end of February 1999. However, data on antibody status does For one of these patients (no. 35), no inhibitor was present in semen fractions after Percoll selection but HCV RNA could not provide a tool to differentiate between current, active infection, chronic infection and past, resolved infection. The clearly be detected in the ejaculate, seminal fluid and cell pellet. He was contaminated by HCV in 1982, and was an aim of the present study was to investigate the detection of HCV RNA in semen and various semen fractions before intravenous drug abuser. The genotype was 3a. Semen data showed a severe oligoasthenoteratozoospermia and 240 000 assisted reproduction in infertile HCV-viraemic male patients. We were able to identify HCV RNA in two semen samples leukocytes were present in the ejaculate.
For the other patient (no. 6), inhibitors were detected in with a lowest detection limit of 100 copies of genome RNA per PCR assay. It is important to note that the tests for HCV fractions 1 (i.e. ejaculate) and 3 (i.e. seminal fluid). After dilution 1:4 of these semen fractions, we observed a positive carried out in this study do not preclude testing for other viruses such as cytomegalovirus (Levy et al., 1997) that might result for a previously negative plasma seminal sample (fraction 3). Patient no. 6 was contaminated by HCV in 1970, and was contaminate the semen. Some recent reports have found a total absence of HCV also an intravenous drug abuser. Semen characteristics were normal with no leukocytes in the semen. The genotype was 1a.
RNA in semen (Hsu et al., 1991; Fried et al., 1992; Terada et al., 1992; Caldwell et al., 1996; Semprini et al., 1998) , The test for PCR inhibitors revealed the presence of Taq polymerase inhibitors in all ejaculates (fraction 1) and seminal while other results suggest that HCV can be detected in the semen with a very low (Fiore et al., 1995) or a high prevalence plasma fractions (fraction 3), except for six samples. Inhibitors were not detected either in cell pellet after centrifugation (Liou et al., 1992; Kotwal et al., 1992; Kotwal, 1993; Liu et al., 1994; Tang et al., 1996) (Table V) . These contradictory (fraction 2), or in semen fractions obtained after Percoll centrifugation (fractions 4, 5, 6 and 7). All motile sperm findings can be explained by differences in collection and/or storage of samples and in the sensitivity of the assays designed samples obtained after Percoll centrifugation were negative for HCV RNA detection (fraction 7).
to detect HCV RNA or antigens. Since PCR can detect tiny amounts of viral RNA, stringent laboratory procedures must For two patients (nos. 15 and 21) with previously negative samples, a second ejaculate was collected 1 month later. Both be employed to avoid false-positive results. The occurrence of false-negative results due to the presence ejaculates were negative for HCV RNA detection. One patient had a retrograde ejaculation: urine was negative for HCV of PCR inhibitors in the ejaculates was an important concern in our study, and for this reason we tested each seminal fraction RNA. A second ejaculate was also collected for patient no. 6 194 831 copies /ml 2 2, 4, 5, 6, 7 negative 1, 3 (negative after dilution) 4.9 mEq/ml 3 2, 5, 6, 7 negative 1, 3, 4 (negative after dilution) Not done 4 1, 2, 4, 5, 6, 7 negative 3 (negative after dilution) Not done 5 2, 4, 5, 6, 7 negative 1, 3 (negative after dilution) 3.8ϫ10 4 copies/ml 6 2, 4, 5, 6, 7 negative 1,3 (3 positive after dilution) 1.7ϫ10 6 copies/ml 7 2, 4, 5, 6, 7 negative 1, 3 (negative after dilution) 0.7 mEq/ml 8 2, 4, 5, 6, 7 negative 1, 3 (negative after dilution) Not done 9 2, 4, 5, 6, 7 negative 1, 3 (negative after dilution) Not done 10 2, 4, 5, 6, 7 negative 1, 3 (negative after dilution) 0.7 mEq/ml 11 b 2 negative 1, 3 (negative after dilution) 5331 copies/ml 12 2, 4, 5, 6, 7 negative 1, 3 (negative after dilution) Not done 13 2, 4, 5, 6, 7 negative 1, 3 (negative after dilution) 0.7 mEq/ml 14 2, 4, 5, 6, 7 negative 1, 3 (negative after dilution) Not done 15 2, 3, 4, 5, 6, 7 negative Absence of inhibitors Not done (no tube 1) 16 2, 4, 5, 6, 7 negative 1, 3 (negative after dilution) Not done 17 1, 2, 3,4,5, 6, 7 negative Absence of inhibitors Not done 18 2, 4, 5, 6, 7 negative 1, 3 (negative after dilution) 3.1ϫ10 5 copies/ml 19 2, 4, 5, 6, 7 negative 1, 3 (negative after dilution) 1.5ϫ10 6 copies/ml 20 b 2, 3 negative Absence of inhibitors 1.1ϫ10 5 copies/ml 21 1, 2, 3, 4, 5, 6, 7 negative Absence of inhibitors 1.7ϫ10 5 copies/ml 22 1, 2, 4, 5, 6, 7 negative 3 (negative after dilution) 1.7ϫ10 6 copies/ml 23 2, 4, 5, 7 negative (no 1, 3 (negative after dilution) 1.3 mEq/ml tube 6) 24 2, 4, 5, 6, 7 negative 1, 3 (negative after dilution) 2.0ϫ10 6 copies/ml 25 2, 4, 5, 6, 7 negative 1, 3 (negative after dilution) 1.1 mEq/ml 26 2, 4, 5, 6, 7 negative 1, 3 (negative after dilution) 1.15ϫ10 6 copies/ml 27 2, 4, 5, 6, 7 negative 1, 3 (negative after dilution) 1 mEq/ml 28 b 2 negative 1, 3 (negative after dilution) 5.4 mEq/ml 29 1, 4, 6, 7 negative Absence of inhibitors 0.6 mEq/ml (no tube 2, 3, 5) 30 2, 4, 5, 6, 7 negative 1, 3 (negative after dilution) 1.1ϫ10 5 copies/ml 31 2, 4, 5, 6, 7 negative 1, 3 (negative after dilution) 33.9 mEq/ml 32 2, 4, 5, 6, 7 negative 1, 3 (negative after dilution) 0.5ϫ10 6 copies/ml 33 2, 4, 5, 6, 7 negative (no 3 (negative after dilution) 5.0ϫ10 6 copies/ml tube 1) 34 2, 4, 5, 6, 7 negative 1, 3 (negative after dilution) 1.0ϫ10 6 copies/ml 35 1, 2, 3, 4 positive Absence of inhibitors 1.6 mEq/ml 5, 6, 7 negative 36 2, 4, 5, 6, 7 negative 1, 3 (negative after dilution) Not done 37 2, 4, 5, 6, 7 negative 1, 3 (negative after dilution) 5.9ϫ10 5 copies/ml 38 2, 4, 5, 6, 7 negative 1, 3 (negative after dilution) 1.1ϫ10 6 copies/ml 39 2, 4, 5, 6, 7 negative 1, 3 (negative after dilution) 1.0ϫ10 6 copies/ml a Blood plasma HCV RNA quantification was determined either by the HCV-Monitor technique (Roche SA, Neuilly-sur-Seine, France), or by the bDNA technique (Chiron Ciba Corning, parc des Bellevues, France): results were expressed as copies of HCV RNA/ml and bDNA mEq/ml respectively. b Semen volume not sufficient for full analysis.
individually with a positive control in each assay. We consider undiluted and 1:4. We consider that the detection of PCR inhibitors is essential but must not represent the end-point of that previous findings reporting the absence of HCV RNA in semen could be due to the technical difficulties in testing the analysis. To complete the analysis, a dilution (e.g. 1:4) may be used to suppress or dilute these PCR inhibitors and unfractionated raw semen and that the presence of RNAses or lipoperoxidases could have interfered with the amplification thus allow a conclusion to be drawn for all patients. Without suppression or dilution of the Taq inhibitors in semen fractions, of nucleic acid and could explain the lack of HCV RNA detection in semen. We demonstrated the presence of Taq no result can be validated. Dilution of the samples can be criticized because of the risk of being under the detection polymerase inhibitors and/or damaging enzymes in Ͼ80% of our unfractionated semen (fraction 1) and/or seminal plasma limit, so we are now testing RNA extraction protocols using silica to eliminate or decrease Taq inhibitors (Tachet et al., (fraction 3) samples (only six semen samples (15.4%) had no inhibitors). In contrast, no inhibitor was detected in fractions 1999). HCV RNA could be clearly identified in semen for two obtained after Percoll centrifugation (where sufficient semen was available for the full analysis). These data led us to test patients. For one patient (no. 6), HCV RNA was only identified in seminal plasma after dilution 1:4. For the other patient (no. two concentrations of each semen sample with inhibitors: HCV-Amplicor procedure was carried out for seven samples: the semen sample, the seminal fluid, the cell pellet and for seminal fluid and the three fractions (90%, 70%, 50%) obtained after Percoll centrifugation. OD ϭ optical density; IC ϭ internal control. et al. (1996) RT-PCR Negative 12 viraemic patients Tang et al. (1996) RT-PCR Positive (57%) 7 viraemic patients McKee et al. (1996) RT-PCR Positive Donor semen No detection after Percoll treatment Fiore et al. (1995) RT-PCR Positive Liu et al. (1994) RT-PCR Positive 3 viraemic patients Liou et al. (1992) RT-PCR Positive (24%) 34 viraemic patients nested PCR Fried et al. (1992) RT-PCR Negative 14 viraemic patients nested PCR Hsu et al. (1991) RT-PCR Negative 19 viraemic patients nested PCR Terada et al. (1991) RT-PCR Negative 6 viraemic patients nested PCR RT ϭ reverse transcription; PCR ϭ polymerase chain reaction; HIV ϭ human immunodeficiency virus. 35), HCV RNA was detected in the ejaculate, the seminal Even if the occurrence of HCV in semen is low, and although HCV infection does not seem to play a significant role in plasma and even in the cell pellet obtained after centrifugation (fractions 1, 2 and 3) which contains leukocytes, spermatozoa infertility, these data must be considered with respect to the risk of HCV transmission not only to the mother and the child and round cells. In both cases, all tests were negative after a three-layer Percoll gradient, which used to be performed but also through laboratory contamination of other non-infected couples' gametes and of technicians, and even through infected routinely (see below) in most infertility centres when preparing the sperm suspension used for IVF or artificial insemination cryopreserved semen storage and manipulation. (fraction 7). Our data are in agreement with McKee et al. (1996) , who noted the elimination of HCV RNA after Percoll
